Veterinary Medicines

Panacur Granules 222 mg/g granulas zirgiem, liellopiem, suņiem un kaķiem

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Panacur Granules 222 mg/g granulas zirgiem, liellopiem, suņiem un kaķiem
Active substance:
  • Fenbendazole
Target species:
  • Horse
  • Cattle
  • Dog
  • Cat
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Fenbendazole
    222.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules
Withdrawal period by route of administration:
  • In-feed use
    • Horse
      • Meat and offal
        5
        day
    • Cattle
      • Meat and offal
        9
        day
      • Milk
        4
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • PVD
Authorisation number:
  • V/NRP/02/1526
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."